Piramal Enterprises is planning to raise fund by issue of Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (NCDs) up to Rs 50 crore along with an option to retain oversubscription up to Rs 650 crore, the total size aggregating up to Rs 700 crore, on a private placement basis. The meeting of the Administrative Committee of the Board of Directors of the company will be held on May 4, 2022, to consider and approve the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
